Synthetic Biologics, Inc. – AMEX:SYN

Synthetic Biologics stock price today

$1.02
Financial Health
0
1
2
3
4
5
6
7
8
9

Synthetic Biologics stock price monthly change

-12.07%
month

Synthetic Biologics stock price quarterly change

+537.90%
quarter

Synthetic Biologics stock price yearly change

+137.21%
year

Synthetic Biologics key metrics

Market Cap
16.16M
Enterprise value
N/A
P/E
-8.5
EV/Sales
N/A
EV/EBITDA
1.94
Price/Sales
N/A
Price/Book
0.26
PEG ratio
-0.13
EPS
-1.17
Revenue
N/A
EBITDA
-21.90M
Income
-18.01M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Synthetic Biologics stock price history

Synthetic Biologics stock forecast

Synthetic Biologics financial statements

Synthetic Biologics, Inc. (AMEX:SYN): Profit margin
Dec 2022 0 -5.15M
Mar 2023 0 -4.47M
Jun 2023 0 -5.08M
Sep 2023 0 -3.30M
Synthetic Biologics, Inc. (AMEX:SYN): Earnings per share (EPS)
2022-05-16 -0.3 -0.3
2022-08-11 -0.35 -0.31
0%
Yield TTM
Synthetic Biologics, Inc. (AMEX:SYN): Payout ratio
Payout ratio 0%
Synthetic Biologics, Inc. (AMEX:SYN): Dividend Yield
2018 3346.83%
2019 63.01%
2020 189.53%
2021 45.1%
2022
Synthetic Biologics, Inc. (AMEX:SYN): Debt to assets
Dec 2022 71861000 17.29M 24.07%
Mar 2023 67886000 17.3M 25.48%
Jun 2023 65449000 17.69M 27.04%
Sep 2023 61545000 17.66M 28.7%
Synthetic Biologics, Inc. (AMEX:SYN): Cash Flow
Mar 2022 -4.90M -4.28M -1.37M
Jun 2022 -4.35M -14K -1.37M
Dec 2022 -5.01M -102K 822K
Mar 2023 -5.61M -8K -55K

Synthetic Biologics alternative data

Synthetic Biologics, Inc. (AMEX:SYN): Employee count
Aug 2023 16
Sep 2023 16
Oct 2023 16
Nov 2023 16
Dec 2023 16
Jan 2024 16
Feb 2024 16
Mar 2024 16
Apr 2024 16
May 2024 16
Jun 2024 16
Jul 2024 16

Synthetic Biologics other data

Synthetic Biologics, Inc. (AMEX:SYN): Insider trades (number of shares)
Period Buy Sel
Dec 2022 100000 0
Jan 2023 50000 0
Feb 2023 50000 0
Jun 2023 40000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SHALLCROSS STEVEN A director, officer: CEO and CFO
Common Stock 14,000 $0.69 $9,702
Purchase
SHALLCROSS STEVEN A director, officer: CEO and CFO
Common Stock 26,000 $0.63 $16,458
Purchase
SHALLCROSS STEVEN A director, officer: CEO and CFO
Common Stock 25,000 $1.04 $26,075
Purchase
SHALLCROSS STEVEN A director, officer: CEO and CFO
Common Stock 25,000 $0.94 $23,525
Purchase
SHALLCROSS STEVEN A officer: CEO and CFO
Common Stock 25,000 $0.87 $21,825
Purchase
SHALLCROSS STEVEN A officer: CEO and CFO
Common Stock 25,000 $0.75 $18,700
Purchase
SHALLCROSS STEVEN A officer: CEO and CFO
Common Stock 100,000 $0.44 $43,700
Purchase
SHALLCROSS STEVEN A director, officer: CEO and CFO
Common Stock 50,000 $0.49 $24,600
Purchase
SHALLCROSS STEVEN A director, officer: CEO and CFO
Common Stock 50,000 N/A N/A
Sale
KIRK RANDAL J 10 percent owner
Common Stock 95,241 N/A N/A
Patent
Application
Filling date: 16 Jul 2020 Issue date: 18 Aug 2022
Application
Filling date: 21 Apr 2022 Issue date: 4 Aug 2022
Application
Filling date: 5 May 2020 Issue date: 14 Jul 2022
Application
Filling date: 5 May 2020 Issue date: 30 Jun 2022
Application
Filling date: 10 Jan 2022 Issue date: 28 Apr 2022
Application
Filling date: 8 Dec 2021 Issue date: 31 Mar 2022
Application
Filling date: 23 Nov 2021 Issue date: 24 Mar 2022
Grant
Filling date: 4 Jun 2020 Issue date: 22 Feb 2022
Grant
Filling date: 24 Jul 2020 Issue date: 1 Feb 2022
Application
Filling date: 19 Aug 2021 Issue date: 6 Jan 2022
Insider Compensation
Mr. Steven A. Shallcross CPA (1961) Chief Executive Officer, Chief Financial Officer, Treasurer, Corporation Sec. & Director
$941,990
Thursday, 11 August 2022
Seeking Alpha
Monday, 16 May 2022
Seeking Alpha
Monday, 9 May 2022
GlobeNewsWire
Tuesday, 19 April 2022
PennyStocks
Wednesday, 16 March 2022
Seeking Alpha
Thursday, 10 March 2022
GlobeNewsWire
Wednesday, 9 February 2022
PRNewsWire
Wednesday, 3 November 2021
Seeking Alpha
Wednesday, 27 October 2021
PennyStocks
Tuesday, 26 October 2021
PRNewsWire
Wednesday, 6 October 2021
PRNewsWire
Tuesday, 21 September 2021
PRNewsWire
Friday, 10 September 2021
InvestorPlace
  • What's the price of Synthetic Biologics stock today?

    One share of Synthetic Biologics stock can currently be purchased for approximately $1.02.

  • When is Synthetic Biologics's next earnings date?

    Unfortunately, Synthetic Biologics's (SYN) next earnings date is currently unknown.

  • Does Synthetic Biologics pay dividends?

    No, Synthetic Biologics does not pay dividends.

  • How much money does Synthetic Biologics make?

    Synthetic Biologics has a market capitalization of 16.16M. Synthetic Biologics made a loss 19.69M US dollars in net income (profit) last year or -$0.31 on an earnings per share basis.

  • What is Synthetic Biologics's stock symbol?

    Synthetic Biologics, Inc. is traded on the AMEX under the ticker symbol "SYN".

  • What is Synthetic Biologics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Synthetic Biologics?

    Shares of Synthetic Biologics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Synthetic Biologics's key executives?

    Synthetic Biologics's management team includes the following people:

    • Mr. Steven A. Shallcross CPA Chief Executive Officer, Chief Financial Officer, Treasurer, Corporation Sec. & Director(age: 64, pay: $941,990)
  • How many employees does Synthetic Biologics have?

    As Jul 2024, Synthetic Biologics employs 16 workers.

  • When Synthetic Biologics went public?

    Synthetic Biologics, Inc. is publicly traded company for more then 32 years since IPO on 12 Feb 1993.

  • What is Synthetic Biologics's official website?

    The official website for Synthetic Biologics is syntheticbiologics.com.

  • Where are Synthetic Biologics's headquarters?

    Synthetic Biologics is headquartered at 9605 Medical Center Dr Ste 270, Rockville, MARYLAND.

  • How can i contact Synthetic Biologics?

    Synthetic Biologics's mailing address is 9605 Medical Center Dr Ste 270, Rockville, MARYLAND and company can be reached via phone at +1 734 332 7800.

Synthetic Biologics company profile:

Synthetic Biologics, Inc.

syntheticbiologics.com
Exchange:

AMEX

Full time employees:

16

Industry:

Biotechnology

Sector:

Healthcare

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral Ăź-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11 to treat cancer. It has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Synthetic Biologics, Inc. is headquartered in Rockville, Maryland.

9605 Medical Center Dr Ste 270
Rockville, MARYLAND 20850

CIK: 0000894158
ISIN: US87164U4094
CUSIP: 87164U409